Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02477098Phase 4Completed
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by China Medical University. Primary endpoint: Interval between leaving the post-anaesthesia care unit and receiving the first PCIA bolus injection at 24 hours. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02477098.